Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Codeine Concerns Cough Up FDA's OTC Monograph Problems

Executive Summary

Pew Charitable Trusts joins CHPA, medical groups in urging Congress to authorize moving the US monograph system to an administrative process and to authorize a monograph user fee program.


Related Content

Opioids: FDA Eyes Better Prescriber Education, But Academics Urge Promotion Crackdown
OTC Monograph Reform, User Fee Legislation Coming 'Any Day' – CHPA
OTC Monograph User Fees Inspire Wary Support From Industry
OTC Monograph 'Disruption' Could Ride Along With PDUFA Reauthorization – CHPA Exec
New Home For OTC Drug Review Would Restore Momentum – Hutt, Yingling
FDA Floats OTC Monograph Overhaul To Be “More Agile And Responsive”





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts